GeekWire

FEBRUARY 3, 2021

Sana Biotechnology — the Seattle upstart that’s looking to treat a variety of diseases through gene therapy and cell engineering — is generating buzz on Wall Street. That would net the biotechnology company $517 million if it sold at the midpoint of that range. But like many emerging biotech companies it is losing money.

Biotechnology 92

Biotechnology .Net Company Engineering 92

GeekWire

FEBRUARY 15, 2022

Adaptive Biotechnologies , which develops technology to assess the immune response, posted $154.3 The number was revealed in the Seattle-based company’s fourth quarter earnings report. Progress on a collaboration with biopharma company Nykode Therapeutics to support the development of a T-cell based COVID-19 vaccine.

Biotechnology 97

Biotechnology .Net Development Study 97

GeekWire

MARCH 18, 2024

Clockwise, from top left: SEngine Precision CEO Carla Grandori; Joon Care CEO Emily Pesce; FlavorCloud CEO Rathna Sharad; AltPep CEO Valerie Daggett; and Strella Biotechnology CEO Katherine Sizov. The 4-year-old company raised $52.9 The GeekWire Awards recognize the top innovators and companies in Pacific Northwest technology.

Company 100

Company Biotechnology Chemicals Survey 100

GeekWire

FEBRUARY 1, 2021

The Seattle and Philadelphia-based company also announced that OMERS Ventures Managing Partner Michael Yang and Carrick Capital Partners Managing Director Jim Madden have stepped down from the board. Ames has served on the board since 2004 and is the former president and CEO of telecommunications company MediaOne International.

Biotechnology 115

Biotechnology Fractional CTO CTO Hire Financial 115

GeekWire

MARCH 9, 2022

Adaptive Biotechnologies has a new CFO. The previous CFO, Chad Cohen , stepped down in February after seven years with the company; he was previously CFO of Zillow Group. Adaptive sells kits to detect COVID-19, “minimal residual disease” for blood cancers, and it partners with vaccine makers and other biopharma companies.

Biotechnology 98

Biotechnology Healthcare Open Source Sports 98

GeekWire

OCTOBER 19, 2021

Sana Biotechnology has a new $50 million tool in its toolbox. Our long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines,” stated the company. Sana CEO and president Steve Harr. Sana Photo).

Biotechnology 131

Biotechnology System Programming Engineering 131

GeekWire

JULY 14, 2020

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work.

Biotechnology 70

Biotechnology Development Microsoft Report 70

GeekWire

AUGUST 23, 2021

based biotech company went public. In a region better known for its tech startups and legions of software engineers, it’s biotech companies that have helped lead a recent IPO boom in the state of Washington, accounting for eight of 11 firms joining the public markets via a traditional IPO over the past year. Absci Photo).

Biotechnology 129

Biotechnology Company Trends Software 129

GeekWire

JUNE 30, 2021

based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built to design and generate protein-based drug candidates and help screen them for optimal functioning. The company took in $1.1 of the company. Absci Photo).

Company 133

Company Biotechnology .Net Programming 133

GeekWire

SEPTEMBER 21, 2021

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. The more 782-employee company will also retain its nearby existing 66,000 square-foot space.

Biotechnology 98

Biotechnology Real Estate Analysis Research 98

GeekWire

FEBRUARY 15, 2022

Madrona has historically backed tech companies but is increasingly investing in companies at the convergence of life and computer sciences, such as A-Alpha Bio, Ozette and Nautilus Biotechnology.

Biotechnology 90

Biotechnology Artificial Intelligence Company Groups 90

GeekWire

JULY 29, 2021

Icosavax is having quite the debut as Washington state’s newest public company. The company, a spin-out from the University of Washington’s Institute for Protein Design , is developing vaccines to resemble naturally occurring viruses. (Photo via Twitter/@icosavax).

Biotechnology 139

Biotechnology Company Pharmaceuticals Research 139

GeekWire

AUGUST 11, 2021

Redfin CEO Glenn Kelman rings the Nasdaq opening bell in 2017 with members of the Seattle company. The Nasdaq stock exchange this month received approval for new rules that encourage companies to appoint more diverse boards of directors. Companies listed on the U.S. How do Pacific NW tech companies stack up?

Biotechnology 103

Biotechnology Company Meeting Nonprofit 103

GeekWire

JUNE 10, 2021

The mobile remittance company said Wednesday it confidentially submitted a draft registration statement with the SEC for its proposed IPO. Only two Washington state companies — Impel Neuropharma and Paymentus — have gone public with a traditional IPO this year. Remitly CEO Matt Oppenheimer. Remitly Photo). Remitly is going public.

Company 143

Company Biotechnology Banking Mobile 143

GeekWire

JULY 22, 2021

based biotech company made its debut as a public company. The company is now valued at nearly $2 billion. Absci joins several other Washington state biotechs that have gone public this year, including Sana Biotechnology , Impel Neuropharma , and Nautilus Biotechnology, which went public via a SPAC merger.

Company 129

Company Biotechnology .Net Development 129

GeekWire

NOVEMBER 3, 2021

on Tuesday, barely three months after going public in an IPO that valued the biotech company at nearly $2 billion. The 200-employee company now has room to expand, with 77,400 square feet of new office and lab space and a 9,150 square foot courtyard. The company leases the space from Pac Trust. “We Washington state Gov.

Company 109

Company Biotechnology Construction Architecture 109

GeekWire

OCTOBER 25, 2021

The executive chairman of life sciences builder Alexandria Real Estate Equities first bought laboratory space in Seattle in 1996 , two years after founding the company when biotech was still emerging as an industry. based company has helped make the Seattle area one of the country’s top ten biotech clusters.

Real Estate 135

Real Estate Company Biotechnology Industry 135

GeekWire

DECEMBER 9, 2022

Banzai , a Seattle marketing software startup, announced Thursday that it will go public after it agreed to merge with a special-purpose acquisition company. The company also said that it will pay $110 million to acquire marketing optimization startup Hyros after the SPAC deal closes. million, for the 12 months ended Sept.

Company 109

Company Biotechnology Virtualization .Net 109

GeekWire

MARCH 31, 2021

Company background : Rodeo was started by gastrointestinal cancer expert Dr. Sanford Markowitz; stem cell and drug development specialist Dr. Stanton Gerson; and regenerative medicine expert Dr. Other backers include AbbVie, Lilly, Arch Venture Partners and Johnson & Johnson. The terms: Amgen will pay $55 million upfront.

Company 97

Company Biotechnology Pharmaceuticals Development 97

GeekWire

AUGUST 6, 2021

For the past 22 years, Cascadia Capital has helped dozens of healthcare, retail, technology and other companies find buyers. Cascadia Capital — led by Michael Butler and Jamie Boyd — filed to raise $150 million for a new special purpose acquisition company, or SPAC, on Thursday by the name of Cascadia Acquisition Corp.

Banking 129

Banking Industry Company Biotechnology 129

GeekWire

JANUARY 4, 2021

The four Washington companies that priced shares in traditional initial public offerings saw their shares increase by 98% or more. Biotechnology companies had a good year. Adaptive Biotechnologies, CTI Biopharma, Aptevo Therapeutics and Silverback Therapeutics posted gains of 99% or more. Adaptive Biotechnologies.

Biotechnology 113

Biotechnology Company Real Estate Apple 113

GeekWire

NOVEMBER 24, 2020

Frazier Healthcare Partners — which has invested in biotechnology companies since 1991 — filed with the Securities and Exchange Commission to raise $100 million for a special purpose acquisition corporation, also known as a SPAC. Over the years, Frazier has bankrolled more than 100 companies, taking more than 60 to IPO or merger.

Biotechnology 73

Biotechnology Company Pharmaceuticals Healthcare 73

GeekWire

NOVEMBER 9, 2023

Adaptive Biotechnologies CEO Chad Robins speaks at the GeekWire Summit in 2019. The reason for the review, Robins said, is to have dedicated focus on each of the businesses since a “competition for resources” has arisen in the company between the two units. “It The company laid off 12% of its workforce last year.

Biotechnology 101

Biotechnology Real Estate .Net Conference 101

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo). The blank check company is called CM Life Sciences III Inc.

Biotechnology 104

Biotechnology Education Web Services Insurance 104

The Verge

JULY 26, 2021

The electronic health record company Epic offers financial incentives to healthcare systems that use its proprietary algorithms — and those algorithms can deliver inaccurate predictions, a Stat News investigation found. The studies that have been done on the algorithms show that they often don’t work as well as advertised.

Company 88

Company Healthcare Biotechnology Financial 88

GeekWire

JULY 18, 2023

After announcing in March that it was seeking “strategic alternatives” for its future, Seattle publicly-traded biotechnology company Neoleukin Therapeutics is now planning to merge with New York City-based Neurogene, a gene therapy startup. The University of Washington spinout also slashed its workforce.

Biotechnology 89

Biotechnology Company Development 89

GeekWire

APRIL 12, 2023

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. based healthcare software company.

Biotechnology 98

Biotechnology Policies Energy Meeting 98

GeekWire

MARCH 18, 2022

Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered doctoral research images that helped to form the initial basis for the company, re-emerged Friday as co-founder and managing general partner of a new investment firm called Propel Bio Partners LP.

Company 109

Company Biotechnology Research Journal 109

GeekWire

JUNE 23, 2020

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle. The company employs 230 people, with offices in Seattle, Cambridge and South San Francisco.

Development 93

Development Company Biotechnology Research 93

GeekWire

JUNE 8, 2020

Airlines and energy companies are seeing notable rallies, The New York Times noted , as social distancing restrictions loosen across the country and oil prices normalize. Tech companies are also contributing to the stock market rebound, including Seattle-area stalwarts Microsoft and Amazon, which are seeing shares reach record high levels.

Microsoft 117

Microsoft Company Biotechnology Travel 117

GeekWire

JULY 8, 2021

Absci researchers at the company’s HQ in Vancouver, Wash. based biotech company Absci reflects a soaring IPO market and adds to the growing prosperity of Pacific Northwest biotech companies. The company pulls employees from both states, said Eric Rosenfeld, founder of the Oregon Venture Fund, an early investor in Absci.

Biotechnology 133

Biotechnology Industry Real Estate Company 133

GeekWire

FEBRUARY 13, 2024

The company, which has locations in the Seattle region and Suzhou, China, has three clinical-stage ADC candidates focused on solid tumors. The company has 95 employees in Suzhou, focused mainly on research and development. The company has 95 employees in Suzhou, focused mainly on research and development. billion last year.

Biotechnology 99

Biotechnology Study Development Groups 99

GeekWire

DECEMBER 7, 2021

Washington state is riding a biotech IPO wave , with five biotech companies entering the public markets in 2021. Sana Biotechnology raised $587 million in its IPO, Absci pulled in $200 million, and vaccine company Icosavax raised more than $180 million.

Real Estate 139

Real Estate Report Company Biotechnology 139

GeekWire

JULY 6, 2021

Former drugstore.com CEO and board chair Dawn Lepore doesn’t need to be convinced that it’s important to have diversity on company boards of directors. To get a sense of where Pacific Northwest companies are starting from, GeekWire researched the board composition of 30 publicly traded technology and biotech corporations in Washington.

Company 113

Company Biotechnology Analysis Real Estate 113

GeekWire

JULY 10, 2020

Some companies have accelerated growth plans, many pivoted or reduced staff, and others are cautiously charging ahead. Companies across other sectors are not only weathering the COVID-19 storm but growing quickly. Last year, there were only two IPOs among GeekWire 200 companies: Adaptive Biotechnologies and Limeade.

B2C 127

B2C Company Education Virtualization 127

GeekWire

AUGUST 2, 2021

The Seattle-based company will begin trading on the NASDAQ Monday under the ticker ROVR, following its merger with Nebula Caravel Acquisition Corp, a publicly-traded SPAC sponsored by True Wind Capital. ” Easterly, a former advertising executive at aQuantive, will continue to lead the company as CEO. and in nine other countries.

Company 121

Company Biotechnology Groups Report 121

GeekWire

APRIL 8, 2024

This category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. The company on Monday published successful results from its latest research. The company on Monday published successful results from its latest research.

Healthcare 99

Healthcare Biotechnology Research CTO 99